TR200000786T2 - Vitronektin reseptör antagonisti - Google Patents

Vitronektin reseptör antagonisti

Info

Publication number
TR200000786T2
TR200000786T2 TR2000/00786T TR200000786T TR200000786T2 TR 200000786 T2 TR200000786 T2 TR 200000786T2 TR 2000/00786 T TR2000/00786 T TR 2000/00786T TR 200000786 T TR200000786 T TR 200000786T TR 200000786 T2 TR200000786 T2 TR 200000786T2
Authority
TR
Turkey
Prior art keywords
receptor antagonist
vitronectin receptor
vitronectin
osteoporosis
useful
Prior art date
Application number
TR2000/00786T
Other languages
English (en)
Inventor
H. Miller William
Original Assignee
Smithkline Beecham Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corporation filed Critical Smithkline Beecham Corporation
Publication of TR200000786T2 publication Critical patent/TR200000786T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cardiology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Bir vitronektin reseptörü antagonisti olup osteoporoz tedavisinde yararli olan bir formül (1) bilesimi veya farmasötik olarak kabul edilebilir bir tuzu açiklanmaktadir.
TR2000/00786T 1997-09-24 1998-09-24 Vitronektin reseptör antagonisti TR200000786T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5986797P 1997-09-24 1997-09-24

Publications (1)

Publication Number Publication Date
TR200000786T2 true TR200000786T2 (tr) 2000-08-21

Family

ID=22025805

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/00786T TR200000786T2 (tr) 1997-09-24 1998-09-24 Vitronektin reseptör antagonisti

Country Status (13)

Country Link
EP (1) EP1023073A1 (tr)
JP (1) JP2002500162A (tr)
KR (1) KR20010024249A (tr)
CN (1) CN1271284A (tr)
AU (1) AU9578798A (tr)
BR (1) BR9813214A (tr)
CA (1) CA2304000A1 (tr)
HU (1) HUP0003931A2 (tr)
IL (1) IL135188A0 (tr)
NO (1) NO20001515L (tr)
PL (1) PL339414A1 (tr)
TR (1) TR200000786T2 (tr)
WO (1) WO1999015178A1 (tr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1150965A4 (en) 1999-02-03 2002-05-15 Merck & Co Inc BENZAZEPINE DERIVATIVES AS ALPHA-V INTGRIN RECEPTOR ANTAGONISTS
US6514964B1 (en) 1999-09-27 2003-02-04 Amgen Inc. Fused cycloheptane and fused azacycloheptane compounds and their methods of use
US20040136949A1 (en) 2001-04-24 2004-07-15 Matthias Grell Combination therapy using anti-angiogenic agents and tnf alpha
KR101159061B1 (ko) 2001-10-22 2012-06-22 더 스크립스 리서치 인스티튜트 항체 표적화 화합물
WO2004089890A2 (en) * 2003-04-04 2004-10-21 Smithkline Beecham Corporation Process and intermediates for preparing benzazepines
CA2554644C (en) 2004-02-02 2015-06-16 Pioneer Hi-Bred International, Inc. Ap2 domain transcription factor odp2 (ovule development protein 2) and methods of use
UA87854C2 (en) 2004-06-07 2009-08-25 Мерк Энд Ко., Инк. N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators
EP2335733B1 (en) 2006-01-18 2014-08-06 Merck Patent GmbH Specific therapy using integrin ligands for treating cancer
PT2101805E (pt) 2007-01-18 2013-01-31 Merck Patent Gmbh Terapia específica e medicamento usando ligandos integrina para tratar o cancro
KR101588469B1 (ko) 2007-11-16 2016-01-25 우베 고산 가부시키가이샤 벤즈아제피논 화합물
US8076475B2 (en) * 2008-03-06 2011-12-13 Glaxosmithkline Llc Process
EP2395992A2 (en) 2009-02-10 2011-12-21 The Scripps Research Institute Chemically programmed vaccination
CA2757396A1 (en) 2009-03-30 2010-10-07 Ube Industries, Ltd. Medical composition for treatment or prophylaxis of eye diseases
EP2445534A2 (en) 2009-05-25 2012-05-02 Merck Patent GmbH Continuous administration of cilengitide in cancer treatments
US8704041B2 (en) 2009-12-30 2014-04-22 Pioneer Hi Bred International Inc Methods and compositions for targeted polynucleotide modification
EP2529018B1 (en) 2009-12-30 2016-06-22 Pioneer Hi-Bred International, Inc. Methods and compositions for the introduction and regulated expression of genes in plants
JP6649902B2 (ja) 2014-05-30 2020-02-19 ファイザー・インク 選択的アンドロゲン受容体モジュレーターとしてのカルボニトリル誘導体
WO2023275715A1 (en) 2021-06-30 2023-01-05 Pfizer Inc. Metabolites of selective androgen receptor modulators

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA60311C2 (uk) * 1996-10-02 2003-10-15 Смітклайн Бічам Корпорейшн Антагоністи рецептора вітронектину, спосіб одержання цих сполук та фармацевтична композиція

Also Published As

Publication number Publication date
CN1271284A (zh) 2000-10-25
KR20010024249A (ko) 2001-03-26
BR9813214A (pt) 2000-08-29
JP2002500162A (ja) 2002-01-08
NO20001515D0 (no) 2000-03-23
NO20001515L (no) 2000-03-23
PL339414A1 (en) 2000-12-18
AU9578798A (en) 1999-04-12
CA2304000A1 (en) 1999-04-01
HUP0003931A2 (hu) 2001-10-28
EP1023073A1 (en) 2000-08-02
WO1999015178A1 (en) 1999-04-01
IL135188A0 (en) 2001-05-20

Similar Documents

Publication Publication Date Title
TR200000786T2 (tr) Vitronektin reseptör antagonisti
TR199801253T2 (tr) Vitronektin reseptörü antagonistleri.
MX9805253A (es) Antagonistas del receptor de vitronectina.
BR0014651A (pt) Inibidores de adesão de célula mediada por "alfa" l beta2
BG106585A (en) Kinase inhibitors as therapeutic agents
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
MX9700041A (es) Antagonistas de receptor de vitronectina.
CZ305838B6 (cs) N-(2-arylethyl)benzylaminy jako antagonisté receptoru 5-HT6
IL133623A0 (en) Antithrombotic agents
IL133627A0 (en) Antithrombotic agents
NO20001514L (no) Vitronectin-reseptor-antagonist
TR200000721T2 (tr) Vitronektin reseptör antagonistleri.
ES2182349T3 (es) Procedimiento de orto-metalizacion para la sintesis de 1-(tetrazol-5-il)bencenos sustituidos en la posicion 2.
TR200403436T2 (tr) Kristalin 1-metilkarbapenem türevleri.
TR199902283T2 (tr) Ikame edilmis izokuinolin türevleri ve bunlarin antikonvulsant olarak kullanimi.
NO975975L (no) Vitronektinreseptor-antagonister, fremstilling samt anvendelse derav
TR200101654T2 (tr) Vitronektin resept”r antagonistleri
TR200001452T2 (tr) Bifenilamidin türevleri.
DE60112960D1 (de) Kondensierte pyridoindolderivate
ATE284871T1 (de) Bicyclische vasopressin-agoniste
DE60121048D1 (de) PYRAZINOi1'2':1,6öPYRIDOi3,4-BöINDOLDERIVATE
TR200200614T2 (tr) Vitronektin reseptörü antagonistleri
CA2278057A1 (en) Tachykinin antagonists
FR2796829B1 (fr) Plaque d'osteotomie tibiale
DK0896822T3 (da) 4-aminopyrrol (3,2-d) pyrimidiner som neuropeptide Y receptorantagonister